Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes renegotiation of their partnership.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

Indian immigrants are the leading group of foreign-born billionaires in the United States, according to the latest Forbes ...

Microsoft has unveiled BioEmu, an advanced AI tool that can simulate protein behavior in mere hours—work that usually takes ...

Indian immigrants are making their mark on billionaires lists. India is currently the leading country of origin for ...

The implications for enterprise AI are significant. Until recently, most leading systems were only available through closed ...

Google wants its AI models to become bigger in coding. It has now hired the CEO of one of the top startups in that area.

Palantir Technologies Inc.'s AI and defense strengths drive growth, but high valuation prompts caution. Click for my updated ...

Microsoft has announced another wave of layoffs, cutting about 9,000 jobs across its global operations. This marks the ...